Rovax 5/80 mg Tablet

Adult dose

Essential Hypertension: It is recommended to administer 80 mg of valsartan orally once daily. Patients whose blood pressure is not well controlled may increase to 160 mg daily or combine with a diuretic. If additional blood pressure reduction is needed, it may be increased to a maximum of 320 mg daily. For elderly patients (75 years and older) and patients with kidney impairment, fluid depletion, mild to moderate liver impairment, the starting dose is 40 mg once daily.

Child dose

Safety and efficacy have not been established in children and adolescents under 18 years of age, so it is not administered.

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; it should be discontinued immediately upon confirmation of pregnancy. It is not safe to use this medication in women who are pregnant or may become pregnant, nursing mothers, patients with severe liver or kidney impairment, and those with muscle disorders. Elderly patients, patients with high potassium levels, patients with slight liver impairment, patients with heart or vascular disease should use this medication carefully, and regular blood tests and kidney function tests may be necessary as required. This medication can cause muscle pain, weakness, and, rarely, rhabdomyolysis (muscle destruction); if symptoms of muscle pain or weakness occur, the healthcare provider should be notified immediately. Furthermore, this medication may affect liver function, so if symptoms of liver dysfunction occur, it should be discontinued and a doctor consulted. There may be interactions with other medications, so if other medications are being taken, be sure to inform a doctor or pharmacist. In the case of overdose, there is no specific antidote, so immediate hospitalization for appropriate treatment is necessary, and appropriate measures are needed if blood pressure becomes excessively low. This medication is not recommended for use in children as safety and effectiveness have not been established. During treatment, driving or operating machinery may cause dizziness, so care should be taken. Lastly, this medication should be kept out of reach of children and not transferred to other containers for safety.

Serious side effects

Hives, severe swelling (edema), angioedema (swelling of face, lips, pharynx, tongue), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucosa, difficulty breathing or shortness of breath, asthma attacks, respiratory distress accompanied by cough + fever, yellowing of skin or eyes (jaundice), extreme fatigue, severe liver dysfunction (jaundice), sudden and severe symptoms.

Mild side effects

Dyspepsia, nausea, dizziness, headache, conjunctival hemorrhage, constipation, weakness, chest pain, facial swelling, peripheral edema, nasopharyngitis, urinary tract infection, bruising, increased serum liver aminotransferase (AST, ALT) levels, increased serum creatine phosphokinase, increased serum potassium, increased gamma-glutamyl transferase, musculoskeletal stiffness, limb pain, sensory disturbance, anxiety, upper respiratory infection, pharyngitis, tonsillitis, spinal stenosis.

This medication may be sensitive to light, so it should be stored in a tightly sealed container that prevents light exposure. It is advisable to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature.

Appearance

Yellow round film-coated tablet

Package unit

30 tablets/box [(10 tablets/PTP) x 3]